BackBioGend Therapeutics , Ltd. Overview

BioGend Therapeutics , Ltd. Total Liabilities

Track BioGend Therapeutics , Ltd.'s total liabilities ($46M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$45.70M
↓ 21.87% YoYΔ $-12.79M vs prior year quarter

Peer trimmed avg / median

Loading

BioGend Therapeutics , Ltd. Total Liabilities History

Loading

BioGend Therapeutics , Ltd. vs. peers: Total Liabilities Comparison

Loading

BioGend Therapeutics , Ltd. Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BioGend Therapeutics , Ltd. (6733.TWO) FAQ

BioGend Therapeutics , Ltd. (6733.TWO) currently reports a total liabilities of $46M as of June 2026. That compares with $58M in the prior-year period — down 21.9% year over year. Use the charts on this page to explore BioGend Therapeutics , Ltd.'s total liabilities history and peer comparisons.

BioGend Therapeutics , Ltd.'s total liabilities decreased from $58M to $46M — a 21.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioGend Therapeutics , Ltd. reported $46M in total liabilities as of June 2026. That compares with $58M in the prior-year period — down 21.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $46M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioGend Therapeutics , Ltd., and consider following 6733.TWO for alerts when major investors trade the stock.

BioGend Therapeutics , Ltd. is classified in the Healthcare sector. On total liabilities, it currently shows $46M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6733.TWO with unrelated industries.